LUMINEX MULTIPLEX ASSAY SERVICE

Rat Inflammatory Cytokine Multiplex Panel (10-Plex)

Simultaneous quantification of 10 key rat inflammatory cytokines and chemokines — covering pro-inflammatory, anti-inflammatory, Th1/Th2/Th17, and chemokine axes — in a single well using Luminex xMAP technology. Designed for preclinical inflammation research, drug efficacy studies, and immune response profiling in rat models.

10 TargetsRat25 μL Samplepg/mL Sensitivity
Request a Quote View Analytes
10-Plex Inflammatory
Brown University
Harvard University
Imperial College London
University of Florida
Tulane University
Abata Therapeutics
AlzeCure Pharma

Inflammation is a fundamental biological response to infection, injury, and immune dysregulation, mediated by a coordinated network of pro-inflammatory cytokines, anti-inflammatory regulators, chemokines, and T cell-derived factors. The rat is the most widely used preclinical model for inflammatory disease research, including rheumatoid arthritis, inflammatory bowel disease, sepsis, neuroinflammation, and drug-induced inflammatory responses. Profiling the inflammatory cytokine network — not just individual markers — is essential for understanding disease mechanisms and evaluating anti-inflammatory therapeutic efficacy.

Creative Proteomics offers the Rat Inflammatory Cytokine 10-Plex Panel based on the Luminex xMAP platform for simultaneous quantification of 10 key inflammatory mediators in a single well. The panel covers pro-inflammatory cytokines (IL-1α, IL-1β, IL-6, TNF-α), T cell/Th1-Th17 cytokines (IFN-γ, IL-2, IL-12p70, IL-17A), anti-inflammatory regulation (IL-10), and inflammatory chemokines (MCP-1, GRO/KC) — providing a balanced view of the inflammatory state. The panel is validated for serum, plasma, and cell culture supernatants, compatible with MAGPIX, Luminex 200, and FLEXMAP 3D systems.

Each analyte is backed by extensive validation data from the Luminex Rat Cytokine/Chemokine panel platform, with intra-assay CV <10% and standard curve ranges spanning 2.4–300,000 pg/mL to cover both physiological and pathological concentrations from a single 25 μL sample.

Panel Specifications
TechnologyLuminex xMAP
Panel Size10-plex
SpeciesRat
Sample TypesSerum, EDTA/Heparin Plasma, CCS
Sample Volume25 μL per well
Sensitivity2.4–24.4 pg/mL (LLOQ, varies by analyte)
Assay Time~4 hours (or overnight option)

Complete Analyte List — 10 Rat Inflammatory Cytokines & Chemokines

The Rat Inflammatory Cytokine 10-Plex Panel covers the major inflammatory axes: pro-inflammatory, Th1/Th2/Th17, anti-inflammatory, and chemokine recruitment.

Target Alternative Name Functional Category Biological Function
IL-1α Interleukin-1 alpha, IL-1F1 Pro-Inflammatory Constitutively expressed alarmin; released upon cell damage/necrosis; activates IL-1R1 to initiate sterile inflammation. Unlike IL-1β, does not require inflammasome processing for activity
IL-1β Interleukin-1 beta, IL-1F2 Pro-Inflammatory Prototypic inflammasome-dependent cytokine; cleaved by caspase-1 following NLRP3/AIM2/NLRC4 activation; potent pyrogen driving fever, hypotension, and acute-phase response
IL-6 Interleukin-6, BSF-2, IFNB2 Pro-Inflammatory / Acute Phase Master coordinator of the acute-phase response; induces hepatic CRP, fibrinogen, and serum amyloid A production; also drives Th17 differentiation (with TGF-β1) and B cell antibody secretion
TNF-α Tumor Necrosis Factor-alpha, Cachectin, TNFSF1A Pro-Inflammatory Early-response cytokine produced primarily by activated macrophages; drives endothelial activation, vascular permeability, and neutrophil recruitment; key therapeutic target in RA, IBD, and psoriasis
IFN-γ Interferon-gamma, Type II IFN Th1 Cytokine Signature Th1 cytokine; activates macrophages for enhanced microbicidal activity; upregulates MHC class I and II; promotes IgG2a class switching in rodents; elevated in autoimmune and infectious disease
IL-2 Interleukin-2, T Cell Growth Factor T Cell Activation Primary T cell growth factor; drives clonal expansion of activated T cells; also essential for regulatory T cell (Treg) survival and function; IL-2/IL-2R axis is a therapeutic target in transplantation and autoimmunity
IL-12p70 Interleukin-12 p70, IL-12A+IL-12B Th1 Polarization Heterodimeric cytokine (p35 + p40 subunits); master inducer of Th1 differentiation; stimulates IFN-γ production from NK and T cells; bridges innate and adaptive immunity; p40 subunit shared with IL-23
IL-17A Interleukin-17A, CTLA-8 Th17 Cytokine Signature Th17 cytokine; induces neutrophil-recruiting chemokines (CXCL1, CXCL8), G-CSF, and antimicrobial peptides from epithelial and stromal cells; critical for mucosal antifungal defense; pathogenic in psoriasis, RA, and MS models
IL-10 Interleukin-10, CSIF Anti-Inflammatory Prototypic anti-inflammatory cytokine; suppresses macrophage and dendritic cell function; inhibits IL-12, TNF-α, and IFN-γ production; essential for immune homeostasis; IL-10 or IL-10R deficiency causes early-onset severe IBD
MCP-1 CCL2, Monocyte Chemoattractant Protein-1 Inflammatory Chemokine Dominant monocyte/macrophage chemoattractant; drives myeloid cell recruitment to sites of inflammation; elevated in atherosclerosis, neuroinflammation, and tumor microenvironment; CCR2/MCP-1 axis is a therapeutic target
Why 10 targets? The panel is designed to answer five fundamental questions about the inflammatory state in a single assay: (1) Is there active inflammation? (IL-1α/β, IL-6, TNF-α), (2) What T cell axis is driving it? (IFN-γ=Th1, IL-17A=Th17), (3) Is there compensatory anti-inflammatory regulation? (IL-10), (4) Is myeloid recruitment occurring? (MCP-1), and (5) Is T cell activation ongoing? (IL-2, IL-12p70). Measuring only a subset of these markers risks missing the dominant inflammatory pathway in a given model.

Don't see the analytes you need in this panel? This 10-plex is a focused subset from a broader Rat Cytokine/Chemokine platform with 27+ available targets. Additional targets can be added (e.g., IL-4, IL-5, IL-13 for Th2; GRO/KC for neutrophils; RANTES, IP-10, Fractalkine for broader chemokine coverage) or removed. Contact us with your target list for a custom panel quote.

Technical Specifications

Validated performance parameters for the Rat Inflammatory Cytokine 10-Plex Panel. Specifications are based on Luminex Rat Cytokine/Chemokine platform validation data.

Platform and Assay
PlatformLuminex xMAP (MAGPIX / Luminex 200 / FLEXMAP 3D)
Panel Size10-plex
SpeciesRat
Sample TypesSerum, EDTA/Heparin Plasma, CCS
Sample Volume25 μL per well
Sample DilutionNeat to 1:2 (serum/plasma)
Assay Time~4 hours (or overnight incubation option)
Performance Metrics
Sensitivity2.4–24.4 pg/mL (LLOQ, varies by analyte)
Standard Curve Range2.4–300,000 pg/mL (IL-6 up to 300K)
Intra-Assay CV<10%
Inter-Assay CV<10–20% (analyte-dependent)
Accuracy80–131% (spike recovery)
Cross-ReactivityNegligible between antibodies within the panel

Luminex Multiplex vs ELISA for Rat Inflammatory Cytokine Analysis

Inflammation is a network phenomenon — measuring one cytokine in isolation provides an incomplete picture. Luminex multiplex captures the full inflammatory state from a single sample.

Parameter Luminex 10-Plex Panel Traditional ELISA (10 assays)
Targets per Well 10 1
Sample Volume 25 μL 250–500 μL total
Assay Time ~4 hours 30–40 hours total
Data Points per Sample 10 1
Inflammatory Balance Insight Pro-inflammatory / anti-inflammatory / chemokine simultaneously Single axis per assay; relationships lost to between-assay variability

The IL-6 / IL-10 ratio is a clinically validated metric of net inflammatory balance in sepsis and trauma research — but it requires simultaneous measurement of both cytokines from the same aliquot to eliminate between-assay variability. Similarly, the IFN-γ / IL-17A ratio distinguishes Th1-dominant from Th17-dominant inflammation, which has direct implications for therapeutic strategy (anti-TNF vs. anti-IL-17). The 10-plex panel enables calculation of these informative ratios from a single 25 μL sample.

Sample Requirements for Rat Inflammatory Cytokine Luminex Assays

Proper sample collection and handling are critical for accurate cytokine measurement. Standardize collection protocols across all animals and time points within a study.

Sample Type Volume Requirement
Serum 25 μL Collect in SST or serum separator tubes; allow clotting at room temperature for 30 min; centrifuge at 1,500g for 10 min. Serial sampling via tail vein or retro-orbital sinus is standard for longitudinal rat studies.
EDTA/Heparin Plasma 25 μL Centrifuge within 30 min of collection at 2,500g for 15 min; platelet-poor plasma recommended to minimize platelet-derived cytokines
Cell Culture Supernatant 50 μL Centrifuge at 10,000g for 10 min to remove cells and debris; splenocyte and lymph node cultures are common sources for ex vivo rat cytokine analysis
Tissue Homogenate 50 μL Homogenize in PBS or lysis buffer with protease inhibitors; centrifuge at 14,000g for 15 min at 4°C; normalize to total protein concentration
Minimum Project Size — One 96-well plate; smaller batches accepted with surcharge
Sample Storage — -80°C; avoid repeated freeze-thaw cycles (>2 cycles may degrade IL-17A and IFN-γ)
Shipping — Dry ice; samples must remain frozen throughout transit

How the Rat Inflammatory 10-Plex Panel Works

Inflammation is not a single pathway — it is a network of interacting pro-inflammatory, anti-inflammatory, and chemotactic signals. The 10-plex panel captures five dimensions of this network simultaneously.

Acute

Acute Inflammatory Response

IL-1α, IL-1β, IL-6, TNF-α — the four core mediators of acute inflammation. IL-1 drives fever and leukocyte recruitment; TNF-α drives endothelial activation; IL-6 coordinates the hepatic acute-phase response. 25 μL per well.

Detects: active tissue-level inflammation
T Cell

T Cell Polarization

IFN-γ, IL-12p70 (Th1), IL-17A (Th17) — determines whether inflammation is driven by Th1 (macrophage-activating), Th17 (neutrophil-recruiting), or mixed pathways. 25 μL per well.

Detects: Th1 vs. Th17 dominance
Regulation

Regulatory & Recruitment

IL-10 (anti-inflammatory), IL-2 (T cell growth/Treg), MCP-1/CCL2 (monocyte chemotaxis) — captures whether inflammation is being actively regulated or amplified with ongoing myeloid recruitment. 25 μL per well.

Detects: compensatory regulation + ongoing recruitment
The IL-6/IL-10 ratio as an inflammatory compass: In LPS-induced systemic inflammation, IL-6 rises rapidly (hours) while IL-10 follows with a delay. An elevated IL-6/IL-10 ratio indicates unchecked acute inflammation. In resolving inflammation, IL-10 predominates and IL-6 declines, shifting the ratio downward. In chronic inflammation (e.g., collagen-induced arthritis), both may be elevated with a variable ratio reflecting disease activity. The 10-plex panel enables tracking of this ratio longitudinally in the same animals, which is particularly valuable in rat models where inter-animal variability is a known confounder.

Rat Inflammatory Cytokine Panel Research Applications

The Rat Inflammatory Cytokine 10-Plex Panel supports preclinical research across autoimmune disease, sepsis, neuroinflammation, and anti-inflammatory drug development.

Rheumatoid Arthritis & Collagen-Induced Arthritis (CIA)

The rat CIA model is the gold standard for RA drug development. TNF-α, IL-6, IL-1β, and IL-17A are the key pathogenic cytokines targeted by biologics. The 10-plex panel enables simultaneous monitoring of all relevant inflammatory axes from serial serum samples during disease induction, peak inflammation, and treatment response — from a single 25 μL per time point.

Sepsis and Systemic Inflammation Models

LPS-induced endotoxemia and cecal ligation and puncture (CLP) models in rats reliably produce systemic cytokine responses. The IL-6/IL-10 ratio is a validated predictor of mortality in experimental sepsis. The panel quantifies both the pro-inflammatory surge (IL-1β, IL-6, TNF-α) and the compensatory anti-inflammatory response (IL-10) from the same sample.

Inflammatory Bowel Disease (IBD) Models

TNBS- and DSS-induced colitis in rats drive mixed Th1/Th17 inflammation with elevated IFN-γ, IL-17A, IL-1β, and IL-6 in colonic tissue and serum. The 10-plex panel enables cytokine profiling from both systemic (serum) and local (tissue homogenate) compartments to assess disease severity and therapeutic response.

Neuroinflammation and CNS Disease

Experimental autoimmune encephalomyelitis (EAE) in rats models multiple sclerosis. IFN-γ and IL-17A are the key effector cytokines, while IL-10 is protective. The panel is suitable for cytokine measurement in serum, CSF, and brain/spinal cord homogenates — minimal sample volume (25 μL) is critical for CSF where total volume per rat is ~100–150 μL.

Anti-Inflammatory Drug Efficacy Studies

Quantify target engagement and pharmacodynamic response for anti-inflammatory drug candidates. For NSAIDs, measure suppression of IL-6 and TNF-α. For anti-IL-17 or anti-TNF biologics, confirm target neutralization and assess compensatory cytokine shifts (e.g., does anti-TNF cause IL-17A upregulation?). Multiplex measurement captures both intended and unintended immunological effects.

Metabolic Inflammation and Obesity

Obesity induces chronic low-grade inflammation (meta-inflammation) characterized by elevated TNF-α, IL-6, and IL-1β from adipose tissue macrophages, with reduced IL-10. Rat models of diet-induced obesity and Zucker diabetic fatty (ZDF) rats are standard platforms for studying the inflammation-metabolism interface. The 10-plex panel is compatible with serum and adipose tissue homogenates.

Deliverables and Quality Metrics

Every Luminex rat inflammatory cytokine assay includes a comprehensive data package with full quality control documentation.

Data Package
  • Raw fluorescence intensities (.csv)
  • Calculated concentrations (pg/mL) for all 10 cytokines/chemokines
  • Inflammatory ratios: IL-6/IL-10, IFN-γ/IL-17A (optional)
  • 5PL standard curves for each analyte (R² >0.99)
  • Full QC report (.xlsx format)
Quality Control
  • Standard curve: 7-point dilution series, 5PL fit, R² >0.99
  • Intra-assay CV <10%
  • Inter-assay CV <10–20%
  • Spike recovery: 80–131%
  • Cross-reactivity: negligible within panel
Assay Performance
  • Duplicate sample measurements for all samples
  • Method summary with reagent lot numbers
  • LLOQ reported per analyte
  • Platform: Luminex xMAP, compatible with MAGPIX, Luminex 200, FLEXMAP 3D

Related Panels

Explore other Luminex panels available for rat inflammatory disease research and preclinical drug development.

Rat Cytokine & Chemokine Panel
  • Targets: IFN-γ, IL-1β, IL-6, TNF-α, MCP-1, RANTES, VEGF
  • Platform: Luminex
  • Plex: 14 to 27-Plex
View Details
Rat Kidney Toxicity Panel
  • Targets: KIM-1, Clusterin, Cystatin C, NGAL, Osteopontin
  • Platform: Luminex
  • Plex: 4/5-Plex
View Details
Rat Cardiovascular Disease Panel
  • Targets: Cardiovascular biomarkers
  • Platform: Luminex
  • Plex: Multiplex
View Details
Mouse Inflammatory Panel
  • Targets: Mouse-specific inflammatory cytokines
  • Platform: Luminex
  • Plex: Multiplex
View Details
Human Inflammation Panel
  • Targets: IL-6, TNF-α, IL-1β, IP-10, IFN-γ
  • Platform: Luminex
  • Plex: 20 to 48-Plex
View Details
Human Cytokine Storm Panel
  • Targets: Cytokine storm-associated markers
  • Platform: Luminex
  • Plex: 21-Plex
View Details
← All Rat PanelsBrowse rat species overview

Frequently Asked Questions About Rat Inflammatory Panel

Common questions about our rat inflammatory cytokine Luminex multiplex panel service.

How does this panel differ from the Rat Cytokine & Chemokine Panel?
The Rat Cytokine & Chemokine Panel (14–27 plex) is a broad-coverage panel that includes growth factors (EGF, VEGF, Leptin, G-CSF), Th2 cytokines (IL-4, IL-5, IL-13), and additional chemokines (RANTES, IP-10, Fractalkine). The Inflammatory 10-Plex is a focused panel designed specifically for inflammation research — it includes IL-17A and MCP-1, which are critical for Th17 and myeloid recruitment assessment but are not always in standard Th1/Th2 panels. Choose the 27-plex for broad discovery; choose the 10-plex for focused, cost-efficient inflammatory profiling in established disease models.
Why is the IL-6/IL-10 ratio important?
IL-6 reflects the magnitude of acute inflammatory activation (tissue-level and hepatic acute-phase response). IL-10 reflects the compensatory anti-inflammatory response that limits tissue damage. A high IL-6/IL-10 ratio indicates inflammation that is outpacing regulatory control — associated with poor outcomes in experimental sepsis, ARDS, and trauma models. A declining IL-6/IL-10 ratio during treatment indicates effective anti-inflammatory intervention. Measuring both simultaneously in the same well eliminates between-assay variability that would invalidate the ratio if measured by separate ELISAs.
Can I replace the 10-plex with just IL-6 and TNF-α measurement?
IL-6 and TNF-α confirm that inflammation is present, but they do not tell you what kind. In the rat CIA arthritis model, TNF-α and IL-6 are elevated in both early and established disease, but IL-17A becomes the dominant driver in the chronic phase — a shift that anti-TNF monotherapy would not capture. Similarly, elevated MCP-1 indicates active monocyte recruitment, which has different therapeutic implications than pure cytokine-driven inflammation. The 10-plex distinguishes between inflammatory phenotypes that require different therapeutic strategies.
What blood collection volume is required from a rat for this panel?
The assay requires only 25 μL of serum or plasma per well. With duplicates, 50 μL is sufficient for the full 10-plex measurement. For comparison, the total circulating blood volume of a 250 g rat is ~16 mL, and serial sampling guidelines allow collection of up to 10% of blood volume (~1.6 mL) every 2 weeks. The 10-plex panel consumes <0.003% of total blood volume per time point, enabling dense serial sampling (daily or every-other-day) without exceeding IACUC blood collection limits.
How do I normalize cytokine data from tissue homogenates?
Cytokine concentrations from tissue homogenates should be normalized to total protein concentration (pg cytokine / mg total protein) to correct for differences in tissue sampling, homogenization efficiency, and tissue density. We recommend performing a BCA or Bradford assay on each homogenate and providing total protein values with your samples. Our QC report will include both raw pg/mL values and protein-normalized values if total protein data is provided.
Can this panel be customized to add or remove specific targets?
Yes. The 10-plex is configured as a focused inflammatory subset from the broader Luminex Rat Cytokine/Chemokine 27-Plex platform. Additional targets can be added (e.g., IL-4, IL-5, IL-13 for Th2 assessment; GRO/KC for neutrophil chemotaxis; RANTES for T cell/eosinophil recruitment) or existing targets removed to match your specific research question. Contact us with your target list for a custom configuration quote.

Interested in Rat Inflammatory Cytokine Profiling?

Contact us to discuss your rat inflammation study requirements, panel configuration (10-plex or custom), and sample collection protocols. We respond within 24 hours.

Request a Quote
For Research Use Only. Not for use in diagnostic or clinical procedures.

Online Inquiry

×
0
Inquiry Basket
Inquiry

Submit the form below to download the PDF!

* I agree to receive other communications from Creative Proteomics, which may contain technical or marketing information. You can unsubscribe from these communications at any time.